BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 27215976)

  • 1. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
    Rajagopalan K; Bacci ED; Ng-Mak D; Wyrwich K; Pikalov A; Loebel A
    BMC Psychiatry; 2016 May; 16():157. PubMed ID: 27215976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.
    Sajatovic M; Forester BP; Tsai J; Kroger H; Pikalov A; Cucchiaro J; Loebel A
    J Clin Psychiatry; 2016 Oct; 77(10):e1324-e1331. PubMed ID: 27529375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A; Cucchiaro J; Silva R; Kroger H; Sarma K; Xu J; Calabrese JR
    Am J Psychiatry; 2014 Feb; 171(2):169-77. PubMed ID: 24170221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lurasidone on meaningful change in health-related quality of life in patients with bipolar depression.
    Calabrese J; Rajagopalan K; Ng-Mak D; Bacci ED; Wyrwich K; Pikalov A; Loebel A
    Int Clin Psychopharmacol; 2016 May; 31(3):147-54. PubMed ID: 26717493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
    Chapel S; Chiu YY; Hsu J; Cucchiaro J; Loebel A
    Clin Ther; 2016 Jan; 38(1):4-15. PubMed ID: 26730454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lurasidone on health-related quality of life in adults with bipolar depression: a post-hoc analysis.
    Dembek C; Fan Q; Niu X; Mao Y; Anupindi VR; Laubmeier K; Tocco M
    Curr Med Res Opin; 2022 Sep; 38(9):1613-1619. PubMed ID: 35699377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L; Ketter TA; Cucchiaro J; Loebel A
    J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
    Calabrese JR; Pikalov A; Streicher C; Cucchiaro J; Mao Y; Loebel A
    Eur Neuropsychopharmacol; 2017 Sep; 27(9):865-876. PubMed ID: 28689688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
    Forester BP; Sajatovic M; Tsai J; Pikalov A; Cucchiaro J; Loebel A
    Am J Geriatr Psychiatry; 2018 Feb; 26(2):150-159. PubMed ID: 29146409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiƶler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY.
    Ketter TA; Sarma K; Silva R; Kroger H; Cucchiaro J; Loebel A
    Depress Anxiety; 2016 May; 33(5):424-34. PubMed ID: 26918425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis.
    Goldberg JF; Siu C; Tocco M; Pikalov A; Loebel A
    J Clin Psychiatry; 2023 Jun; 84(4):. PubMed ID: 37339360
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
    J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lurasidone: a review of its use in adult patients with bipolar I depression.
    Sanford M; Dhillon S
    CNS Drugs; 2015 Mar; 29(3):253-63. PubMed ID: 25698146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
    Loebel A; Cucchiaro J; Silva R; Kroger H; Hsu J; Sarma K; Sachs G
    Am J Psychiatry; 2014 Feb; 171(2):160-8. PubMed ID: 24170180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial.
    Rajagopalan K; Bacci ED; Wyrwich KW; Pikalov A; Loebel A
    Int J Bipolar Disord; 2016 Dec; 4(1):7. PubMed ID: 26928122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study.
    DelBello MP; Goldman R; Phillips D; Deng L; Cucchiaro J; Loebel A
    J Am Acad Child Adolesc Psychiatry; 2017 Dec; 56(12):1015-1025. PubMed ID: 29173735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.